PNGAF (The Precision Peptide Co) EBIT: $-2.52 Mil (TTM As of Jan. 2026)


PNGAF The Precision Peptide Co Inc PNGAF
21 GF Score
Price $0.34
! 4 Warning Signs
View Full Analysis

What is The Precision Peptide Co EBIT?

The Precision Peptide Co PNGAF -1.93% 21 EBIT is $-2.52 Mil as of Jan. 2026. GuruFocus rates PNGAF with a GF Score™ of 21/100. The stock has 4 warning signs investors should review.

The Precision Peptide Co's earnings before interest and taxes (EBIT) for the three months ended in Jan. 2026 was $-1.04 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jan. 2026 was $-2.52 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. The Precision Peptide Co's annualized ROC % for the quarter that ended in Jan. 2026 was %. The Precision Peptide Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2026 was %.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. The Precision Peptide Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jan. 2026 was -16.84%.

The Precision Peptide Co  (OTCPK:PNGAF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

The Precision Peptide Co's annualized ROC % for the quarter that ended in Jan. 2026 is calculated as:

ROC % (Q: Jan. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Oct. 2025 ) + Invested Capital (Q: Jan. 2026 ))/ count )
=-4.172 * ( 1 - 0% )/( (0 + 0)/ 2 )
=-4.172/0
= %

where

Invested Capital(Q: Oct. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0.952 - 0.287 - ( 0.686 - max(0, 0.287 - 0.952+0.686))
=0

Invested Capital(Q: Jan. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0.473 - 0.277 - ( 0.301 - max(0, 0.277 - 0.473+0.301))
=0

Note: The Operating Income data used here is four times the quarterly (Jan. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

The Precision Peptide Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jan. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Jan. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Oct. 2025  Q: Jan. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-4.172/( ( (0 + max(-0.068, 0)) + (0 + max(-0.156, 0)) )/ 2 )
=-4.172/( ( 0 + 0 )/ 2 )
=-4.172/0
= %

where Working Capital is:

Working Capital(Q: Oct. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.004 + 0.05 + 0.165) - (0.287 + 0 + 0)
=-0.068

Working Capital(Q: Jan. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0.045 + 0.076) - (0.277 + 0 + 0)
=-0.156

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jan. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

The Precision Peptide Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jan. 2026 )
=-2.523/14.979
=-16.84 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Precision Peptide Co EBIT Related Terms

The Precision Peptide Co EBIT Historical Data

* Premium members only.

The historical data trend for The Precision Peptide Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Precision Peptide Co EBIT Chart

The Precision Peptide Co Annual Data
Trend Oct21 Oct22 Oct23 Oct24 Oct25
EBIT
0.00 -0.66 -1.18 -0.67 -1.61

The Precision Peptide Co Quarterly Data
Jul21 Oct21 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.14 -0.19 -0.49 -0.80 -1.04

PNGAF vs KHC, GIS: EBIT Comparison

For the Packaged Foods subindustry, The Precision Peptide Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The Precision Peptide Co EV-to-EBIT vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, The Precision Peptide Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where The Precision Peptide Co's EV-to-EBIT falls into.


PNGAF
21GF Score
The Precision Peptide Co Inc PNGAF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Precision Peptide Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-2.52 Mil mean?
The Precision Peptide Co (PNGAF) has a EBIT of $-2.52 Mil as of Jan. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on The Precision Peptide Co.
Is The Precision Peptide Co's EBIT too high?
The Precision Peptide Co's current EBIT is $-2.52 Mil. Overall, The Precision Peptide Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does The Precision Peptide Co's EBIT compare to KHC and GIS?
The Precision Peptide Co's EBIT of $-2.52 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Consumer Packaged Goods company?
A good EBIT depends on the Consumer Packaged Goods industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on The Precision Peptide Co. The Precision Peptide Co's current EBIT is $-2.52 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Precision Peptide Co stock overvalued right now?
The Precision Peptide Co (PNGAF) has a current EBIT of $-2.52 Mil. The current EBIT is $-2.52 Mil. The Precision Peptide Co's overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For The Precision Peptide Co (PNGAF), the current EBIT is $-2.52 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Precision Peptide Co Business Description

Other Exchanges XU0:GermanyBPC:Canada
Address 130th Street, Suite 8035, Surrey, BC, CAN, V3W 0H7
The Precision Peptide Co Inc is a food manufacturer and distributor of nutritional supplements, functional snacks, natural foods, peptides, and natural personal care products. The company offers end-to-end services from formulation and ingredient sourcing to final packaging and fulfillment. The Company has two reportable operating segments: the manufacturing and distribution of food products in Canada and the sale and delivery of its peptide products in the United States.
21GF Score

Get the complete analysis for PNGAF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.34
Price